No trial date has been set for Shire Ltd.’s patent infringement suits against Barr, Mylan, Inc., Mylan Pharmaceuticals, Inc., and Matrix Laboratories, Inc., and Natco Pharma Limited.
In February 2009, Shire…
Sandoz Inc.’s appeal relating to the patent infringement case, Shire v Impax, remains pending, according to Shire Ltd.’s latest Quarterly Report filed with the U.S. Securities and Exchange Commission.
The U.S.…
Generics UK Ltd.’s appeal to the ruling in its rectification action against Shire Ltd. will be heard in October 2009.
Generics UK seeks a declaration that the duration of the Supplementary…
No trial date has been set for Shire Ltd.’s suit against Teva Pharmaceuticals Industries Ltd. for the alleged infringement of U.S. Patent Nos. 5,912,013 and 5,326,570.
Both patents relate to carbamazepine.
The…
Genzyme Corporation is pursuing a Hectorol patent infringement action against Roxane Laboratories, Inc., in the U.S. District Court for the District of Delaware.
On July 31, 2009, the company filed a…